Dr. Vladimir Cmiljanovic
Chief Executive Officer
Dr. Vladimir Cmiljanovic is a renowned serial biotech entrepreneur, cancer scientist, and medicinal chemist with over 15 years of experience in oncology drug development.
Dr. Natasa Cmiljanovic
Chief Operating Officer
Dr. Natasa Cmiljanovic is a dynamic and accomplished professional, serving as the Chief Operating Officer and Founder of Swiss Rockets. With over a decade of invaluable experience in oncology drug development, Natasa's background as a medicinal chemist and clinical scientist makes her a driving force in the field.
Dr. Josef Künzle
Chief Quality Officer
Dr. Josef Künzle is an expert responsible for establishing and maintaining the company’s Pharmaceutical Quality Management System.
Albert Muntane Casanova
Chief Financial Officer
Albert Muntane Casanova is an accomplished manager responsible for overseeing the financial activities of the company.
Dr. Doriano Fabbro
Chief Scientific Officer
Dr. Doriano Fabbro is a renowned drug discovery and kinase expert with more than 20 years’ experience in the pharmaceutical industry, following 10 years in academia. Until 2005, Doriano was an Executive Director for the Oncology Drug Discovery Division of the Novartis Institute for Biomedical Research (NIBR) in Basel, Switzerland and was a member of the NIBR Oncology Advisory Board overseeing the oncology portfolio from target discovery to clinical development.
Dr. Milan Crnogorac
Chief Technology Officer
Dr. Milan Crnogorac is an experienced executive responsible for providing strategic, financial and operational leadership for the Technical Operations, Project Management and CapEx spending.
Dr. Bruno Osterwalder
Chief Medical Officer
Dr. Bruno Osterwalder is an esteemed figure in the realm of hematology and oncology, with a wealth of experience spanning 15 years in academic clinical practice. With Swiss board certifications, his journey has been a testament to his expertise in internal medicine, hematology, and oncology.